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NOVEL DELETIONS AND UNUSUAL GENETIC MECHANISMS UNDERLYING  
ALPHA-THALASSEMIA 
INTRODUCTION 
Hemoglobin (Hb) is a protein responsible for oxygen transportation from lungs to the entire body. It is composed by four globular subunits - the globins - each with a central core 
containing a heme molecule. Globins are encoded by the α- and β-globin gene clusters located at 16p13.3 and 11p15.5, respectively1. The pattern of globin genes expression during 
development is precisely controlled by the interaction of cis-regulatory genomic regions (located in close proximity to and far from genes) with trans-activating/silencing factors within 
permissive chromatin domains.  In fact, approximately 25-65 kb upstream of the α-globin genes there are four multispecies conserved sequences (MCS-R1 to R4) which are critical for 
the expression regulation of the downstream globin genes1,2. 
The main objectives of this work were to characterize the molecular lesions underlying eleven unusual cases of α-thalassemia or Hb H disease (Table I), and to understand their 
origin and functional consequences. 
METHODS 
Multiplex Ligation-dependent Probe Amplification (MLPA) is appropriated to investigate large chromosomic regions, searching for changes in the copy number of a certain DNA 
sequence. It consists of two adjacent oligonucleotides hybridization followed by their ligation and amplification by PCR. Only the hybridized and ligated oligonucleotides (MLPA 
probe) will amplify according to the amount of target sequence present in the genome. Each MLPA reaction allows the amplification of several probes with only one set of primers. 
Capillary electrophoresis is used to separate MLPA amplification products based on their size. In this study, each sample was tested in duplicate and compared to the average result 
of three normal controls in the same assay. The peak areas were used in the subsequent graphic analysis. 
In order to study genomic regions not contemplated by commercial MLPA probes (SALSA MLPA P140B HBA), we designed synthetic probes according to MCR-Holland 
instructions. Whenever possible gap-PCR and automatic Sanger sequencing were used to confirm MLPA results and map deletion breakpoints.  
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We have found seven different large deletions in the alpha-
globin gene cluster (ranging from ≈ 3.3 to 323 kb), four of 
them not previously described (Table I, Figure 1). 
 The four largest deletions removed all the α-globin genes 
(Del. 1, 2, 3, and 4), whereas the other three deletions (Del. 5, 
6, and 7) removed one or more of the distal regulatory 
elements keeping the globin genes structurally intact.  
 In one case (Del.7), only the MCS-R2 (also known as HS-
40) was removed and replaced by a 39nt DNA fragment 
(Figure 2) possibly resulting from a complex rearrangement 
that introduces new pieces of DNA (probably from Chrs. 3 and 
7) bridging the two deletion breakpoints. This rearrangement 
has been previously described by our group in another family3.  
 In the remaining case, no deletion (No Del.) was found and 
the patient revealed to be a very unusual case of acquired 
alpha-thalassemia-myelodysplastic syndrome (ATMDS). We 
will further investigate the ATRX gene for somatic mutations4.   
 
It is important to detect individuals with this type of uncommon deletions as there is a 25% risk of having a child with Hb Bart’s hydrops fetalis or Hb H disease if their partner is a 
carrier of an α0-thal or α+-thal  allele, respectively. Moreover, further investigation is currently being developed on one of these natural mutants which is bringing new insights into the 
long-range regulation mechanism of the globin gene expression and to the pathophysiology of the α-thalassemia. 
Patient 
Gender/ 
Age (yrs) 
Geographic 
origin 
Hematological and biochemical parameters α-globin 
cluster 
deletion 
RBC 
(1012/L) 
Hb  
(g/dL) 
MCV 
 (fL) 
MCH  
(pg) 
HbA2  
(%) 
1 F /17 Portuguese 5.47 10.4 63.2 19 2.4 Del.1 
2 F /39 Portuguese 5.41 11.5 68.0 21.3 - Del.1 
3 F/36 Portuguese 5.02 11.4 71.9 22.8 2.3 Del.2# 
 4* F/? Portuguese 4.96 11.0 70.9 22.1 2.5 Del.2# 
5 F/11 Sweden - 11.0 65.0 20.0 - Del.3# 
6 F/21 Portuguese 5.19 11.4 69.3 22 2.3 Del.4# 
7 F/40 Portuguese 5.2 10.5 65 20.1 2.2 Del.5# 
 8* M/10 Portuguese 5.31 10.8 64.7 20.3 2.5 Del.5# 
9 F/31 Portuguese 5.03 10.7 68.2 21.4 2.3 Del.6 
10 M/? Portuguese 5.41 11.9 67.4 21.9 - Del.7 
11 F/61 Portuguese 4.19 7.7 71.6 18.3 1.9 No Del. 
RBC: red blood cell count; Hb: hemoglobin;  MCV: mean corpuscular volume; MCH: mean corpuscular 
hemoglobin; 
Patient 4* is the sister of patient 3; Patient 8* is the son of patient 7;  
# novel deletions. 
  
 
Table I - Demographic, hematological and biochemical data of the patients 
 
Fig. 2 completar  
Alpha-thalassemia-myelodysplastic syndrome (ATMDS) 
Patient 11 presents an acquired microcytic, hypochromic anemia and normal iron status. Two years earlier she had normal hemoglobin and hematimetric parameters. 
There is no family history of hematologic disorder and iron metabolism deficiency. Results from isoelectric focusing suggested the presence of  Hb H. It was confirmed and 
quantitated (29.7%) by capillary hemoglobin electrophoresis. Supravital staining of the patient’s peripheral blood demonstrated approximately 50% of Hb H-containing cells. 
Analysis of the α-globin loci by MLPA denoted no deletion. The Sanger sequencing of HBA1 and HBA2 did not reveal pathogenic gene variants.  
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Figure 1. (A) Schematic representation of 4 Mb from the sub-telomeric region of chr16p, containing the α-globin gene cluster. MLPA probe hybridization sites are indicated 
by green and orange arrows referring to commercial and synthetic probes, respectively. Each probe is numbered according to their sequential order of chromosomal 
hybridization. Probe density might not allow individual numbering and therefore probe intervals are shown. Black bars represent deleted DNA sequence as determined by 
MLPA analysis. Thin lines indicate the region of uncertainty for deletion breakpoints. The oval shape represents the telomere. MCS-Rs are represented by vertical dark grey 
bars in or nearby NPRL3 gene. (B) MLPA probe ratios (y-axis) were determined by comparison of their signal quantification in the studied individuals and in normal controls. 
MLPA probe numbers are displayed in the x-axis. Deleted sequences present a probe amplification ratio around 0.5 when in heterozygosity and around zero when the target 
sequence is deleted in both alleles (exceptions include probes nos. 33 and 36 which hybridize in both HBA2 and HBA1 and therefore, ratio can vary by 0.25 fold). Probe no. 
37 is amplified only in the presence of Hb Constant Spring (). *Indicates breakpoint location of deletion 4 in the α-globin gene cluster detailed region. 
A Del. 7 = 3.3 kb deletion + 39 nt sequence insertion  B 
Figure 2. (A) Sanger sequencing chromatogram 
of the Del.7 showing the 39 nt sequence insertion 
bridging the two deletion breakpoints; 
 (B) The 39 nt sequence resulted from a complex 
rearrangement that introduced new pieces of DNA 
(probably from Chrs. 3 and 7) and two nts (CC) 
from unknown origin. 
Adapted from mfold (http://unafold.rna.albany.edu/?q=mfold) 
